Drug – bio-affecting and body treating compositions – Designated organic active ingredient containing – Peptide containing doai
Patent
1992-10-27
1995-02-07
Draper, Garnette D.
Drug, bio-affecting and body treating compositions
Designated organic active ingredient containing
Peptide containing doai
514 8, 514 12, 514886, 514887, 530350, C07K 1500, A01N 3700
Patent
active
053875761
ABSTRACT:
Pharmaceutical preparations for the treatment of hyperproliferative epidermal conditions comprising the specific negative growth factor activin A, and their use in methods of treatment of hyperproliferative epidermal conditions.
REFERENCES:
patent: 4798885 (1989-01-01), Mason et al.
Korotkii et al. 1985 Vestn. Dermatol. Venerol. 0(7):48-51.
Bowman & Rand 1980, Textbook of Pharmacology 2nd Blackwell Scientific Publications Oxford, Selected pages.
Choi, Y., et al., "TGF-Beta and retinoic acid: regulators of growth and modifiers of differentiation in human epidermal cells", Cell Regulation, 1:791-809 (1990).
Lyons, K., et al., "Vgr-1, a mammalian gene related to Xenopus Vg-1, is a member of the transforming growth factor Beta gene superfamily", Proc. Natl. Acad. Sci. USA, 86:4554-4558 (1989).
Bullough W.S., et al., "The control of epidermal mitotic activity in the mouse", Proc. Roy. Soc. B., 151:517-536 (1959).
Bichel, P. "Tumor Growth Inhibiting Effect of JP-I Ascitic Fluid-I" Europ. J. Cancer 6:291-296 (1970).
Albano, R. M., et al., "mesoderm-inducing factor produced by WEHI-3 murine myelomonocytic leukemia cells is activin A", Development, 110:435-443 (1990).
Ausubel, et al. "In Situ Hybridization and Immunohistochemistry" Current Protocols in Molecular Biology.
Schubert, D., et al., "Activin is a nerve cell survival molecule" Nature, 344:868-870 (1990).
Green, H., "The Keratinocyte as differentiation cell type", The Harvey Lectures, Series 74, 101-139, (1979).
Dvir, A., et al., "The Inhibition of EGF-dependent Proliferation of Keratinocytes by Tyrphostin Tyrosine Kinase Blockers" The J. of Cell Biol., (113):857-865 (1991).
Smith, J. C., et al., "Identification of a potent Xenopus mesoderm-inducing factor as a homologue of activin A", Nature, 345:729-731 (1990).
Asashima, M., et al., "Mesodermal induction in early amphibian embryos by activin A (erythroid differentiation factor)", Roux's Arch. Dev. Biol. (198):330-335 (1990).
Mason, A. J., et al., "Complementary DNA sequences of ovarian follicular fluid inhibin show precursor structure and homology with transforming growth factor-beta", Nature, (318):659-663 (1985).
Ling, Nicholas, et al. "Pituitary FSH is released by a heterodimer of the Beta-subunits from the two forms of inhibin", Nature, (321):779-782 (1986).
Vale, W., et al., "Purification and characterization of an FSH releasing protein from porcine ovarian follicular fluid" Nature, (321):776-779 (1986).
Thomsen, G., et al., "Activins Are Expressed Early in Xenopus Embryogenesis and Can Induce Axial Moesoderm and Anterior Structures", Cell, (63):485-493 (1990).
Jones, C. M., et al., "Involvement of Bone Morphogenetic Protein-4 (BMP-4) and Vgr-1 in morphogenesis and neurogenesis in the mouse" Development, 111:531-542 (1991).
Mitrani, E., et al., "Induction by Soluble Factors of Organized Axial Structures in Chick Epiblasts", Science, 247:1092-1094 (1990).
Mitrani, E., et al., "Activin Can Induce the Formation of Axial Structures and Is Expressed in the Hypoblast of the Chick", Cell 63-495-501 (1990).
Bichel, P., "Specific Growth Regulation in Three Ascitic Tumours" Europ. J. Cancer, 8:167-173 (1972).
Fearon E. R., et al., "A Genetic Model for Colorectal Tumorigenesis"Cell, 61:759-767 (1990).
Weiss, P., et al., "A Model of Growth & Growth Control in Mathematical Terms", J. Gen. Physiol., 41(1):1-47 (1957).
Boukamp, P. et al., "Evironmental Modulation of the Expression of Differentiation . . . Carcinoma Cell Lines", Cancer Research, 45:5582-5592 (1985).
Trotter, N. L., "The Effect of Partial Hepatectomy on Subcutaneously Transplanted Hepatomas in Mice", Cancer Research, 21:778-782 (1961).
Rheinwald, J. G., "Serial Cultivation of Normal Human Epidermal Keratinocytes", Methods in Cell Biology, 21A:229-254 (1980).
Murata, M., et al., "Erythroid differentiation factor is encoded by the same mRNA as that of the inhibin Beta.sub.A chain", Proc. Natl. Acad. Sci USA, 85:2434-2438 (1988).
Thompson, N. L., et al., "Expression of Transforming Growth Factor-Betal in Specific . . . Neonatal Mice", J. of Cell. Biol., 108:661-669 (1989).
Pelton, R. W., et al., "Expression of transforming growth factor Beta2 RNA during murine embryogenesis", Development, 106:759-767 (1989).
Mathews L. S., et al., "Expression Cloning of an Activin Receptor, a Predicted Transmembrane Serine Kinase", Cell, 65:973-982 (1991).
Weinstein, G. D., et al., "Fraction of labelled mitoses studies in normal and psoriatic skin" In: Psoriasis Cell Proliferation, Eds. Wright, N. et al., pp. 34-44 (1983).
Pinkus, H., "Examination of the Epidermis by the Strip Method of Removing horny layers", J. of Invest. Derm., 383-386 (1951).
Abercrombie, M., "Localized formation of new tissue in an adult mammal" Dept. of Anatomy & Embryology, Univ. College, London Symposium Soc. Exp. Biol. 11:235-254 (1957).
Burns, E. R., "On the Failure of Self-Inhibition of Growth in Tumors" Growth, 33:25-45 (1969).
Yu, J., et al., "Importance of FSH-Releasing protein and inhibin in erythrodifferentiation", Nature, 330:765-767 (1987).
Cairns, J., "Mutation selection and the natural history of cancer" Nature, 255:197-201 (1975).
Carlson K. Cochrane
Draper Garnette D.
Yissum Research Development Co.
LandOfFree
Treatment of hyperproliferative epidermal conditions with activi does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Treatment of hyperproliferative epidermal conditions with activi, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Treatment of hyperproliferative epidermal conditions with activi will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1110381